Bruce & Co., Inc. Mannkind Corp Transaction History

Bruce & Co., Inc.

$250 Million
Q3 2025

A detailed history of Bruce & Co., Inc. transactions in Mannkind Corp stock. As of the latest transaction made, Bruce & Co., Inc. holds 195,073 shares of MNKD stock, worth $987,069. This represents 0.42% of its overall portfolio holdings.

Number of Shares

195,073

Previous 195,073 -0.0%

Holding current value

$987,069

Previous $729,000 43.62%

% of portfolio

0.42%

Previous 0.31%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$2.67 - $4.77 $534,000 - $953,999	-200,000 Reduced 50.62%	195,073 $743,000
Q2 2021 Aug 16, 2021	SELL	$3.61 - $5.45 $1.81 Million - $2.73 Million	-500,000 Reduced 55.86%	395,073 $2.15 Million
Q1 2021 May 17, 2021	BUY	$3.14 - $6.14 $2.71 Million - $5.3 Million	863,238 Added 2711.6%	895,073 $3.51 Million
Q4 2020 Feb 16, 2021	SELL	$1.79 - $4.04 $184,833 - $417,166	-103,259 Reduced 76.43%	31,835 $99,000
Q3 2020 Nov 13, 2020	SELL	$1.56 - $2.08 $780,000 - $1.04 Million	-500,000 Reduced 78.73%	135,094 $253,000

Q2 2020 Aug 14, 2020	BUY	$0.94 - $2.21 $431,808 - $1.02 Million	459,371 Added 261.42%	635,094 $1.11 Million
Q1 2020 May 15, 2020	SELL	$0.84 - $1.76 $1.01 Million - $2.11 Million	-1,200,000 Reduced 87.23%	175,723 $180,000
Q4 2019 Feb 14, 2020	SELL	$1.14 - $1.49 $1.08 Million - $1.41 Million	-949,056 Reduced 40.82%	1,375,723 $1.77 Million
Q3 2019 Nov 14, 2019	BUY	$1.04 - $1.44 $2.42 Million - $3.35 Million	2,324,779 New	2,324,779 $2.91 Million
Q4 2018 Feb 15, 2019	SELL	$1.02 - $2.05 $102,000 - $204,999	-100,000 Closed	0 $0
Q3 2018 Nov 09, 2018	SELL	$1.01 - $2.19 $202,000 - $438,000	-200,000 Reduced 66.67%	100,000 $183,000
Q2 2018 Aug 14, 2018	BUY	$1.59 - $2.38 $477,000 - $714,000	300,000 New	300,000 $600,000

Others Institutions Holding MNKD

# of Institutions

257

Shares Held

165M

Call Options Held

2.76M

Put Options Held

689K

View Full List

About MANNKIND CORP

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.3B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

More about MNKD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bruce & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bruce & Co., Inc. with notifications on news.

Account